{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:03:19Z","timestamp":1789984999640,"version":"4.0.1"},"reference-count":102,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Health Science Reports"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Stevens\u2010Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), and erythema multiforme major (EM major) are severe dermatologic conditions characterized by varying degrees of skin detachment and involvement of mucosal membranes, often triggered by drug reactions or infections. The management of these conditions poses a significant challenge due to the potential for rapid progression to life\u2010threatening complications. Recently, emerging therapeutic approaches such as Tumor Necrosis Factor\u2010alpha (TNF\u2010\u03b1) blockers and Janus Kinase (JAK) inhibitors have shown promise in regulating the dysregulated immune response implicated in these disorders. A comprehensive literature review was conducted to evaluate the efficacy and safety of TNF\u2010\u03b1 blockers and JAK inhibitors in treating SJS, TEN, and EM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review was conducted according to PRISMA guidelines. A comprehensive literature search was performed in PubMed, Scopus, Embase, Web of Science, and Google Scholar, up to September 5, 2025, on JAK inhibitors and TNF inhibitors in treating SJS, TEN, or EM major.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The current review studies 82 articles (748 patients), including case reports, cohort studies, and clinical trials. Various JAK inhibitors and TNF inhibitors, such as tofacitinib, etanercept, adalimumab, and infliximab, were assessed regarding effectiveness in treating SJS\/TEN and EM. Notably, some cases demonstrated a rapid response to these inhibitors, resulting in faster re\u2010epithelialization and a reduction in the severity of lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>TNF\u2010\u03b1 blockers like infliximab and etanercept show promise for patients unresponsive to standard treatments, shortening acute phases, reducing hospitalization, and mortality rates, and enhancing healing. Further research, especially registry\u2010based studies, is crucial. Healthcare practitioners are advised to exercise caution and reserve novel drugs for managing hypersensitivity reactions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hsr2.72668","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:21:57Z","timestamp":1781875317000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Systematic Review of Literature: TNF\u2010\u03b1 Blockers and JAK Inhibitors for the Treatment of Stevens\u2010Johnson Syndrome, Toxic Epidermal Necrolysis, and Severe Forms of Erythema Multiforme"],"prefix":"10.1002","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1940-8842","authenticated-orcid":false,"given":"Sadaf","family":"Salehi","sequence":"first","affiliation":[{"name":"School of Medicine Iran University of Medical Sciences Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7312-2007","authenticated-orcid":false,"given":"Pooneh","family":"Torabi","sequence":"additional","affiliation":[{"name":"School of Medicine Iran University of Medical Sciences Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3180-7619","authenticated-orcid":false,"given":"Mahsa","family":"Abbaspour","sequence":"additional","affiliation":[{"name":"School of Medicine Iran University of Medical Sciences Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6323-9252","authenticated-orcid":false,"given":"Nima","family":"Hajizadeh","sequence":"additional","affiliation":[{"name":"School of Medicine Iran University of Medical Sciences Tehran Iran"},{"name":"Department of Dermatology, Hazrat Fatemeh Hospital, School of Medicine Iran University of Medical Sciences Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1657-1487","authenticated-orcid":false,"given":"Sara","family":"Sadeghi","sequence":"additional","affiliation":[{"name":"School of Medicine Iran University of Medical Sciences Tehran Iran"},{"name":"Department of Medicine, NY Health and Hospitals South Brooklyn Health Brooklyn New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5878-9778","authenticated-orcid":false,"given":"Alireza","family":"Jafarzadeh","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hazrat Fatemeh Hospital, School of Medicine Iran University of Medical Sciences Tehran Iran"},{"name":"Skin and Stem Cell Research Center Tehran University of Medical Sciences Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1249-4429","authenticated-orcid":false,"given":"Azadeh","family":"Goodarzi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hazrat Fatemeh Hospital, School of Medicine Iran University of Medical Sciences Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57090895"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30378-6"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8667-7"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.24748.1"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.5668"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-017-0530-y"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14118"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cden.2013.07.001"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.651247"},{"key":"e_1_2_14_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.11.034"},{"key":"e_1_2_14_12_1","doi-asserted-by":"crossref","unstructured":"Toxic Epidermal Necrolysis Successfully Treated With Infliximab. Journal of the American Academy of Dermatology. 2012;66(4):AB168.","DOI":"10.1016\/j.jaad.2011.11.707"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.06.029"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12954-6"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12029"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0462"},{"key":"e_1_2_14_17_1","volume-title":"Quality Assessment Tool for Case Series Studies","author":"National Heart, Lung, and Blood Institute","year":"2014"},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2017-110853"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.06.441"},{"key":"e_1_2_14_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2016.10.009"},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18256"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.4084"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.07.022"},{"key":"e_1_2_14_24_1","first-page":"S199","volume-title":"Pediatric Blood & Cancer","author":"Marlowe E.","year":"2023"},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/ski2.185"},{"key":"e_1_2_14_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/1203475418758989"},{"key":"e_1_2_14_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpccr.2022.100162"},{"key":"e_1_2_14_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12832"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13330"},{"key":"e_1_2_14_30_1","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v102.2243"},{"key":"e_1_2_14_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2009.00616.x"},{"key":"e_1_2_14_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2022.09.009"},{"key":"e_1_2_14_33_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1K001"},{"key":"e_1_2_14_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/jbcr\/iraa194"},{"key":"e_1_2_14_35_1","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-26.7.758"},{"key":"e_1_2_14_36_1","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0277"},{"key":"e_1_2_14_37_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1210026"},{"key":"e_1_2_14_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2023.03.637"},{"key":"e_1_2_14_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13862"},{"key":"e_1_2_14_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.07.1949"},{"key":"e_1_2_14_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.02.299"},{"key":"e_1_2_14_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15006"},{"key":"e_1_2_14_43_1","doi-asserted-by":"publisher","DOI":"10.5070\/D3241037941"},{"issue":"8","key":"e_1_2_14_44_1","article-title":"Toxic Epidermal Necrolysis Post COVID\u201019 Vaccination \u2010 First Reported Case","volume":"13","author":"Bakir M.","year":"2021","journal-title":"Cureus"},{"key":"e_1_2_14_45_1","doi-asserted-by":"publisher","DOI":"10.25259\/IJDVL_61_20"},{"key":"e_1_2_14_46_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2020.3883"},{"key":"e_1_2_14_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.04.044"},{"key":"e_1_2_14_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17540"},{"key":"e_1_2_14_49_1","first-page":"S72","article-title":"Etanercept for Toxic Epidermal Necrolysis: A Confirm on Efficacy and Safety","volume":"135","author":"Didona B.","year":"2015","journal-title":"Journal of Investigative Dermatology"},{"key":"e_1_2_14_50_1","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/16-060"},{"key":"e_1_2_14_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.3731"},{"key":"e_1_2_14_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2008.04020.x"},{"key":"e_1_2_14_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.06.256"},{"key":"e_1_2_14_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa034"},{"key":"e_1_2_14_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsi.2012.06.005"},{"key":"e_1_2_14_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.07.036"},{"issue":"4","key":"e_1_2_14_57_1","first-page":"258","article-title":"Systemic Immunomodulating Therapies FOR Stevens\u2010Johnson Syndrome and Toxic Epidermal Necrolysis IN A COVID\u201019 Patient","volume":"23","author":"Ganfornina Andrades A.","year":"2021","journal-title":"A CASE REPORT. European jclinpharm."},{"key":"e_1_2_14_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.14179"},{"key":"e_1_2_14_59_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.3731"},{"key":"e_1_2_14_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15006"},{"key":"e_1_2_14_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2018.12.018"},{"key":"e_1_2_14_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.07.118"},{"key":"e_1_2_14_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.06.257"},{"key":"e_1_2_14_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2022.05.009"},{"key":"e_1_2_14_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/jbcr\/iry006.090"},{"key":"e_1_2_14_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.01.038"},{"key":"e_1_2_14_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.01.039"},{"key":"e_1_2_14_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2011.01396.x"},{"key":"e_1_2_14_69_1","doi-asserted-by":"publisher","DOI":"10.12788\/cutis.0288"},{"key":"e_1_2_14_70_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI93349"},{"issue":"6","key":"e_1_2_14_71_1","first-page":"5727","article-title":"Severe Erythema Multiforme\u2010Type Drug Eruption Controlled by Tumor Necrosis factor\u2010\u03b1 Antagonist: A Case Study","volume":"14","author":"Ling X.","year":"2017","journal-title":"Experimental and Therapeutic Medicine"},{"key":"e_1_2_14_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.15143"},{"issue":"11","key":"e_1_2_14_73_1","first-page":"716","article-title":"Adalimumab Combined With Glucocorticoid in the Treatment of One Pediatric Case of Stevens\u2010Johnson Syndrome and Review of the Literature","volume":"37","author":"Zang X.","year":"2021","journal-title":"China J Lepr Skin Dis"},{"key":"e_1_2_14_74_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S401286"},{"key":"e_1_2_14_75_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1188523"},{"key":"e_1_2_14_76_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13911"},{"key":"e_1_2_14_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.02.058"},{"key":"e_1_2_14_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2016.11.009"},{"key":"e_1_2_14_79_1","first-page":"117","article-title":"Antitumour Necrosis Factor\u2010A Therapy to Treat Toxic Epidermal Necrolysis: A New Therapeutic Option?","volume":"165","author":"Scott\u2010Lang V.","year":"2011","journal-title":"British Journal of Dermatology"},{"key":"e_1_2_14_80_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3246196"},{"key":"e_1_2_14_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2012.04357.x"},{"issue":"1","key":"e_1_2_14_82_1","first-page":"61","article-title":"Toxic Epidermal Necrolysis Successfully Treated With Infliximab","volume":"23","author":"Z\u00e1rate\u2010Correa L. C.","year":"2013","journal-title":"Journal of Investigational Allergology & Clinical Immunology"},{"key":"e_1_2_14_83_1","doi-asserted-by":"publisher","DOI":"10.1080\/00015550510037062"},{"key":"e_1_2_14_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2010.00893.x"},{"key":"e_1_2_14_85_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.46833.x"},{"key":"e_1_2_14_86_1","doi-asserted-by":"publisher","DOI":"10.1080\/00015550510037062"},{"key":"e_1_2_14_87_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.02026.x"},{"key":"e_1_2_14_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2012.01863.x"},{"key":"e_1_2_14_89_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13924"},{"key":"e_1_2_14_90_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13778"},{"issue":"4","key":"e_1_2_14_91_1","article-title":"Complete Remission in a Child With Multisystem Inflammatory Syndrome and Stevens\u2010Johnson Syndrome Treated With Infliximab","volume":"15","author":"Lootah S.","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"e_1_2_14_92_1","article-title":"Long\u2010Term Complications of Toxic Epidermal Necrolysis Successfully Treated With Infliximab","volume":"182","author":"Plant A.","year":"2020","journal-title":"British Journal of Dermatology"},{"key":"e_1_2_14_93_1","doi-asserted-by":"publisher","DOI":"10.1159\/000338202"},{"key":"e_1_2_14_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2014.01.027"},{"key":"e_1_2_14_95_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.4083"},{"key":"e_1_2_14_96_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.5889"},{"key":"e_1_2_14_97_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200809020-00006"},{"key":"e_1_2_14_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07149.x"},{"issue":"6","key":"e_1_2_14_99_1","first-page":"375","article-title":"[Treatment by Thalidomide of Chronic Multiforme Erythema: Its Recurrent and Continuous Variants. A Retrospective Study of 26 Patients]","volume":"123","author":"Cherouati K.","year":"1996","journal-title":"Annales De Dermatologie et de Venereologie"},{"key":"e_1_2_14_100_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1992.tb08415.x"},{"key":"e_1_2_14_101_1","doi-asserted-by":"publisher","DOI":"10.2340\/0001555562449450"},{"issue":"8","key":"e_1_2_14_102_1","first-page":"525","article-title":"Recombinant Human Tumor Necrosis Factor Receptor Type Ii\u2010Igg Fc Fusion Protein With Glucocorticoid Successfully Treat Stevens\u2010Johnson Syndrome: A Case Report","volume":"37","author":"Wh L.","year":"2021","journal-title":"China Journal of Leprosy and Skin Diseases"},{"issue":"6","key":"e_1_2_14_103_1","first-page":"428","article-title":"Recombinant Human Tumor Necrosis factor\u2010\u03b1 Receptor \u2171: Igg Fc Fusion Protein for the Treatment of Drug\u2010Induced Toxic Epidermal Necrolysis: A Multicenter Clinical Observation","volume":"53","author":"Lu X.","year":"2020","journal-title":"Chin J Dermatol"}],"container-title":["Health Science Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hsr2.72668","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hsr2.72668","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hsr2.72668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:20:15Z","timestamp":1789982415000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hsr2.72668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":102,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1002\/hsr2.72668"],"URL":"https:\/\/doi.org\/10.1002\/hsr2.72668","archive":["Portico"],"relation":{},"ISSN":["2398-8835","2398-8835"],"issn-type":[{"value":"2398-8835","type":"print"},{"value":"2398-8835","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"2025-09-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e72668"}}